Tiprelestat was safe and well tolerated, with initial signs of clinical efficacy Kiel, Germany, December 9, 2024 – tiakis Biotech AG, a clinical-stage biopharmaceutical company developing novel ...
8, 2024 — Patients with acute myeloid leukemia who have lower education and income are less likely to receive a allogeneic hematopoietic ... Fred Hutch does not endorse or verify the accuracy of any ...
The Transparency Company, a pioneer in review verification technology, has released a groundbreaking report, "The High Cost of Review Fraud: An Economic Analysis of Consumer Harm." This comprehensive ...
“If we are to meet the goal of destigmatising HIV and having zero transmissions by 2030 then we need to ensure that we adopt a hauroa Maori approach. That means aside from improving access to testing ...